What is the current annual EBITDA of CI?

As of today, CI annual EBITDA is $8.04B

What is 1-year change in CI annual EBITDA?

CI annual EBITDA is down -5.90% year-over-year

What is 3-year change in CI annual EBITDA?

CI annual EBITDA is down -17.11% over the past 3 years

How far is CI annual EBITDA from its all-time high?

CI annual EBITDA is currently -41.16% below its historical high of $13.67B set on December 31, 2020

How does CI annual EBITDA rank versus sector peers?

CI annual EBITDA is higher than 98.39% of companies in Healthcare sector

When is CI next annual earnings release?

The next annual earnings release for CI is on February 5, 2026

What is the current quarterly EBITDA of CI?

As of today, CI quarterly EBITDA is $2.99B

What is CI quarterly EBITDA most recent change?

CI quarterly EBITDA was up +10.69% on September 30, 2025

What is 1-year change in CI quarterly EBITDA?

CI quarterly EBITDA is up +62.43% year-over-year

How far is CI quarterly EBITDA from its all-time high?

CI quarterly EBITDA is currently -50.88% below its historical high of $6.09B set on December 31, 2020

How does CI quarterly EBITDA rank versus sector peers?

CI quarterly EBITDA is higher than 98.55% of companies in Healthcare sector

When is CI next earnings release?

The next earnings release for CI is on February 5, 2026

What is the current TTM EBITDA of CI?

As of today, CI TTM EBITDA is $10.67B

What is CI TTM EBITDA most recent change?

CI TTM EBITDA was up +12.08% on September 30, 2025

What is 1-year change in CI TTM EBITDA?

CI TTM EBITDA is up +68.27% year-over-year

How far is CI TTM EBITDA from its all-time high?

CI TTM EBITDA is currently -22.71% below its historical high of $13.81B set on March 31, 2021

How does CI TTM EBITDA rank versus sector peers?

CI TTM EBITDA is higher than 98.37% of companies in Healthcare sector

When is CI next earnings release?

The next earnings release for CI is on February 5, 2026

The Cigna Group (CI) EBITDA History & Chart Since 1980

Annual EBITDA

$8.04B$504.00M-5.90%

December 31, 2024

Summary

Current Value: As of today, CI annual EBITDA is $8.04B, down -5.90% on December 31, 2024
Historical Performance: CI annual EBITDA is down -17.11% over the past 3 years, and down -21.30% over the past 5 years
All-Time High Comparison: CI annual EBITDA is currently -41.16% below its historical high of $13.67B set on December 31, 2020
3-Year Low Comparison: CI annual EBITDA is at its 3-year low
Sector Comparison: CI annual EBITDA is higher than 98.39% of companies in Healthcare sector

EBITDA Chart

Add series to chart

Add series to chart1/6

Performance

CI Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 24	$8.04B	-5.9%	-17.1%	-21.3%	+271.4%
Quarterly EBITDA	Sep 30, 25	$2.99B	+62.4%	-29.1%	+19.4%	+454.1%
TTM EBITDA	Sep 30, 25	$10.67B	+68.3%	-5.5%	+9.3%	+408.7%
Price	Jan 16, 26	$272.21	-3.1%	-13.4%	+24.4%	+580.0%
PE Ratio	Jan 16, 26	12.01	-47.7%	-17.9%	+26.6%	+46.8%
Annual Revenue	Dec 31, 24	$244.38B	+25.2%	+40.2%	+59.0%	+1223.8%
Annual EPS	Dec 31, 24	$12.12	-30.3%	-22.9%	-9.8%	+156.3%
Annual EBIT	Dec 31, 24	$5.27B	-4.4%	-22.3%	-19.8%	+177.6%
Annual Net Income	Dec 31, 24	$3.78B	-29.7%	-30.2%	-26.2%	+189.7%

EBITDA Highs

CI Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$11.33B	N/A	-29.0%
5Y	$13.67B	N/A	-41.2%
All	$13.67B	Dec 31, 20	-41.2%

EBITDA Lows

CI Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$8.04B	Dec 31, 24	at low
5Y	$8.04B	Dec 31, 24	at low
All	-$42.50M	Dec 1, 84	>+9999.0%

EBITDA History

Year	Value	Change
2024	$8.04B	-5.9%
2023	$8.55B	-24.6%
2022	$11.33B	+16.8%
2021	$9.71B	-29.0%
2020	$13.67B	+33.7%
2019	$10.22B	+139.0%
2018	$4.28B	+2.5%
2017	$4.17B	+16.2%
2016	$3.59B	-8.3%
2015	$3.91B	+0.5%
2014	$3.89B	+40.4%
2013	$2.77B	-8.7%
2012	$3.04B	+36.7%

Year	Value	Change
2011	$2.22B	+2.7%
2010	$2.16B	-0.2%
2009	$2.17B	+248.2%
2008	$622.00M	-65.9%
2007	$1.83B	-5.9%
2006	$1.94B	-3.7%
2005	$2.01B	+4,838.8%
1984	-$42.50M	-117.4%
1983	$244.50M	-49.2%
1982	$481.50M	+20.6%
1981	$399.29M	+6.5%
1980	$374.85M	-

FAQ

What is the current annual EBITDA of CI?
As of today, CI annual EBITDA is $8.04B
What is 1-year change in CI annual EBITDA?
CI annual EBITDA is down -5.90% year-over-year
What is 3-year change in CI annual EBITDA?
CI annual EBITDA is down -17.11% over the past 3 years
How far is CI annual EBITDA from its all-time high?
CI annual EBITDA is currently -41.16% below its historical high of $13.67B set on December 31, 2020
How does CI annual EBITDA rank versus sector peers?
CI annual EBITDA is higher than 98.39% of companies in Healthcare sector
When is CI next annual earnings release?
The next annual earnings release for CI is on February 5, 2026

Quarterly EBITDA

$2.99B$289.00M+10.69%

September 30, 2025

Summary

Current Value: As of today, CI quarterly EBITDA is $2.99B, up +10.69% on September 30, 2025
Historical Performance: CI quarterly EBITDA is up +62.43% year-over-year, and down -29.05% over the past 3 years
All-Time High Comparison: CI quarterly EBITDA is currently -50.88% below its historical high of $6.09B set on December 31, 2020
3-Year Low Comparison: CI quarterly EBITDA is +264.88% above its 3-year low of $820.00M reached on March 31, 2024
Sector Comparison: CI quarterly EBITDA is higher than 98.55% of companies in Healthcare sector

Performance

CI Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 25	$2.99B	+10.7%	+62.4%	-29.1%	+19.4%
Annual EBITDA	Dec 31, 24	$8.04B	–	-5.9%	-17.1%	-21.3%
TTM EBITDA	Sep 30, 25	$10.67B	+12.1%	+68.3%	-5.5%	+9.3%
Price	Jan 16, 26	$272.21	-6.5%	-3.1%	-13.4%	+24.4%
PE Ratio	Jan 16, 26	12.01	-6.5%	-47.7%	-17.9%	+26.6%
Quarterly Revenue	Sep 30, 25	$69.77B	+3.8%	+11.2%	+54.4%	+70.2%
Quarterly EPS	Sep 30, 25	$6.98	+22.2%	+165.9%	-22.1%	+84.7%
Quarterly EBIT	Sep 30, 25	$2.30B	+13.6%	+92.5%	-34.3%	+27.2%
Quarterly Net Income	Sep 30, 25	$1.97B	+20.9%	+139.2%	-29.0%	+41.1%

Quarterly EBITDA Highs

CI Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$2.99B	Sep 30, 25	at high
3Y	$2.99B	Sep 30, 25	at high
5Y	$6.09B	N/A	-50.9%
All	$6.09B	Dec 31, 20	-50.9%

Quarterly EBITDA Lows

CI Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$2.32B	Mar 31, 25	+28.9%
3Y	$820.00M	Mar 31, 24	+264.9%
5Y	$820.00M	Mar 31, 24	+264.9%
All	-$1.23B	Sep 30, 02	+343.6%

Quarterly EBITDA History

Month	Value	Change
Sep 2025	$2.99B	+10.7%
Jun 2025	$2.70B	+16.4%
Mar 2025	$2.32B	-12.5%
Dec 2024	$2.66B	+44.1%
Sep 2024	$1.84B	-32.5%
Jun 2024	$2.73B	+232.6%
Mar 2024	$820.00M	-14.0%
Dec 2023	$953.00M	-63.4%
Sep 2023	$2.61B	-1.3%
Jun 2023	$2.64B	+12.3%
Mar 2023	$2.35B	+12.3%
Dec 2022	$2.09B	-50.4%
Sep 2022	$4.22B	+53.9%
Jun 2022	$2.74B	+20.0%
Mar 2022	$2.28B	+11.1%
Dec 2021	$2.06B	-26.4%
Sep 2021	$2.79B	+6.2%
Jun 2021	$2.63B	+18.0%
Mar 2021	$2.23B	-63.4%
Dec 2020	$6.09B	+143.1%
Sep 2020	$2.51B	-16.0%
Jun 2020	$2.98B	+42.7%
Mar 2020	$2.09B	-4.5%
Dec 2019	$2.19B	-18.2%
Sep 2019	$2.68B	+0.1%
Jun 2019	$2.67B	-0.5%
Mar 2019	$2.69B	+453.6%
Dec 2018	$485.00M	-59.4%
Sep 2018	$1.20B	-3.5%
Jun 2018	$1.24B	-8.8%
Mar 2018	$1.36B	+51.1%
Dec 2017	$899.00M	-6.6%
Sep 2017	$963.00M	-24.4%
Jun 2017	$1.27B	+23.0%
Mar 2017	$1.04B	+37.2%
Dec 2016	$755.00M	-15.4%
Sep 2016	$892.00M	-7.6%
Jun 2016	$965.00M	-1.2%
Mar 2016	$977.00M	+23.2%
Dec 2015	$793.00M	-22.8%
Sep 2015	$1.03B	-5.5%
Jun 2015	$1.09B	+8.2%
Mar 2015	$1.01B	+13.6%
Dec 2014	$885.00M	-8.2%
Sep 2014	$964.00M	-7.3%
Jun 2014	$1.04B	+3.7%
Mar 2014	$1.00B	+45.8%
Dec 2013	$688.00M	-27.2%
Sep 2013	$945.00M	+3.2%
Jun 2013	$916.00M	+308.9%
Mar 2013	$224.00M	-71.0%
Dec 2012	$773.00M	-9.5%
Sep 2012	$854.00M	+16.7%
Jun 2012	$732.00M	+8.0%
Mar 2012	$678.00M	+29.1%
Dec 2011	$525.00M	+46.2%
Sep 2011	$359.00M	-46.8%

Month	Value	Change
Jun 2011	$675.00M	+2.0%
Mar 2011	$662.00M	+4.6%
Dec 2010	$633.00M	+17.2%
Sep 2010	$540.00M	+6.7%
Jun 2010	$506.00M	+4.8%
Mar 2010	$483.00M	-15.1%
Dec 2009	$569.00M	+3.6%
Sep 2009	$549.00M	-22.2%
Jun 2009	$706.00M	+106.4%
Mar 2009	$342.00M	+223.5%
Dec 2008	-$277.00M	-193.6%
Sep 2008	$296.00M	-37.9%
Jun 2008	$477.00M	+278.6%
Mar 2008	$126.00M	-71.0%
Dec 2007	$435.00M	-21.1%
Sep 2007	$551.00M	+48.1%
Jun 2007	$372.00M	-20.3%
Mar 2007	$467.00M	+16.2%
Dec 2006	$402.00M	-18.6%
Sep 2006	$494.00M	+7.2%
Jun 2006	$461.00M	-20.8%
Mar 2006	$582.00M	+62.1%
Dec 2005	$359.00M	-18.6%
Sep 2005	$441.00M	-9.4%
Jun 2005	$487.00M	-33.0%
Mar 2005	$727.00M	-10.7%
Dec 2004	$814.00M	+41.6%
Sep 2004	$575.00M	-29.0%
Jun 2004	$810.00M	+116.6%
Mar 2004	$374.00M	-21.4%
Dec 2003	$476.00M	+35.6%
Sep 2003	$351.00M	+1,626.1%
Jun 2003	-$23.00M	-106.7%
Mar 2003	$345.00M	+185.1%
Dec 2002	$121.00M	+109.9%
Sep 2002	-$1.23B	-433.7%
Jun 2002	$368.00M	-5.9%
Mar 2002	$391.00M	+16.0%
Dec 2001	$337.00M	-29.1%
Sep 2001	$475.00M	+7.7%
Jun 2001	$441.00M	-7.9%
Mar 2001	$479.00M	+5.0%
Dec 2000	$456.00M	-5.2%
Sep 2000	$481.00M	+57.7%
Jun 2000	$305.00M	-35.9%
Mar 2000	$476.00M	-4.4%
Dec 1999	$498.00M	+4,427.3%
Sep 1999	$11.00M	-97.9%
Jun 1999	$512.00M	+5.6%
Mar 1999	$485.00M	+14.4%
Dec 1998	$424.00M	-7.2%
Sep 1998	$457.00M	-8.8%
Jun 1998	$501.00M	-40.8%
Mar 1998	$846.00M	+372.6%
Dec 1997	$179.00M	+431.5%
Jun 1997	-$54.00M	-200.0%
Mar 1997	$54.00M	-

FAQ

What is the current quarterly EBITDA of CI?
As of today, CI quarterly EBITDA is $2.99B
What is CI quarterly EBITDA most recent change?
CI quarterly EBITDA was up +10.69% on September 30, 2025
What is 1-year change in CI quarterly EBITDA?
CI quarterly EBITDA is up +62.43% year-over-year
How far is CI quarterly EBITDA from its all-time high?
CI quarterly EBITDA is currently -50.88% below its historical high of $6.09B set on December 31, 2020
How does CI quarterly EBITDA rank versus sector peers?
CI quarterly EBITDA is higher than 98.55% of companies in Healthcare sector
When is CI next earnings release?
The next earnings release for CI is on February 5, 2026

TTM EBITDA

$10.67B$1.15B+12.08%

September 30, 2025

Summary

Current Value: As of today, CI TTM EBITDA is $10.67B, up +12.08% on September 30, 2025
Historical Performance: CI TTM EBITDA is up +68.27% year-over-year, and down -5.52% over the past 3 years
All-Time High Comparison: CI TTM EBITDA is currently -22.71% below its historical high of $13.81B set on March 31, 2021
3-Year Low Comparison: CI TTM EBITDA is +68.27% above its 3-year low of $6.34B reached on September 30, 2024
Sector Comparison: CI TTM EBITDA is higher than 98.37% of companies in Healthcare sector

Performance

CI Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 25	$10.67B	+12.1%	+68.3%	-5.5%	+9.3%
Annual EBITDA	Dec 31, 24	$8.04B	–	-5.9%	-17.1%	-21.3%
Quarterly EBITDA	Sep 30, 25	$2.99B	+10.7%	+62.4%	-29.1%	+19.4%
Price	Jan 16, 26	$272.21	-6.5%	-3.1%	-13.4%	+24.4%
PE Ratio	Jan 16, 26	12.01	-6.5%	-47.7%	-17.9%	+26.6%
TTM Revenue	Sep 30, 25	$268.22B	+2.7%	+16.8%	+49.0%	+70.8%
TTM EPS	Sep 30, 25	$22.67	+23.8%	+113.8%	+8.1%	+58.9%
TTM EBIT	Sep 30, 25	$7.97B	+16.1%	+131.2%	-4.5%	+18.1%
TTM Net Income	Sep 30, 25	$6.55B	+21.3%	+95.6%	-2.1%	+22.9%

TTM EBITDA Highs

CI TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$10.67B	Sep 30, 25	at high
3Y	$11.40B	Mar 31, 23	-6.4%
5Y	$13.81B	Mar 31, 21	-22.7%
All	$13.81B	Mar 31, 21	-22.7%

TTM EBITDA Lows

CI TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$8.04B	N/A	+32.7%
3Y	$6.34B	Sep 30, 24	+68.3%
5Y	$6.34B	Sep 30, 24	+68.3%
All	-$785.00M	Jun 30, 03	+1459.5%

TTM EBITDA History

Month	Value	Change
Sep 2025	$10.67B	+12.1%
Jun 2025	$9.52B	-0.3%
Mar 2025	$9.55B	+18.7%
Dec 2024	$8.04B	+26.8%
Sep 2024	$6.34B	-10.8%
Jun 2024	$7.11B	+1.3%
Mar 2024	$7.02B	-17.9%
Dec 2023	$8.55B	-11.8%
Sep 2023	$9.69B	-14.3%
Jun 2023	$11.30B	-0.9%
Mar 2023	$11.40B	+0.6%
Dec 2022	$11.33B	+0.3%
Sep 2022	$11.30B	+14.4%
Jun 2022	$9.87B	+1.1%
Mar 2022	$9.76B	+0.6%
Dec 2021	$9.71B	-29.4%
Sep 2021	$13.74B	+2.1%
Jun 2021	$13.45B	-2.6%
Mar 2021	$13.81B	+1.0%
Dec 2020	$13.67B	+40.0%
Sep 2020	$9.77B	-1.7%
Jun 2020	$9.94B	+3.2%
Mar 2020	$9.63B	-5.8%
Dec 2019	$10.22B	+20.0%
Sep 2019	$8.52B	+21.0%
Jun 2019	$7.04B	+25.6%
Mar 2019	$5.60B	+31.0%
Dec 2018	$4.28B	-8.8%
Sep 2018	$4.69B	+5.2%
Jun 2018	$4.46B	-0.8%
Mar 2018	$4.49B	+7.7%
Dec 2017	$4.17B	+3.6%
Sep 2017	$4.03B	+1.8%
Jun 2017	$3.96B	+8.5%
Mar 2017	$3.65B	+1.6%
Dec 2016	$3.59B	-1.0%
Sep 2016	$3.63B	-3.6%
Jun 2016	$3.76B	-3.1%
Mar 2016	$3.88B	-0.7%
Dec 2015	$3.91B	-2.3%
Sep 2015	$4.00B	+1.6%
Jun 2015	$3.94B	+1.2%
Mar 2015	$3.89B	+0.1%
Dec 2014	$3.89B	+5.3%
Sep 2014	$3.70B	+0.5%
Jun 2014	$3.68B	+3.5%
Mar 2014	$3.55B	+28.1%
Dec 2013	$2.77B	-3.0%
Sep 2013	$2.86B	+3.3%
Jun 2013	$2.77B	+7.1%
Mar 2013	$2.58B	-14.9%
Dec 2012	$3.04B	+8.9%
Sep 2012	$2.79B	+21.6%
Jun 2012	$2.29B	+2.5%
Mar 2012	$2.24B	+0.7%
Dec 2011	$2.22B	-4.6%
Sep 2011	$2.33B	-7.2%

Month	Value	Change
Jun 2011	$2.51B	+7.2%
Mar 2011	$2.34B	+8.3%
Dec 2010	$2.16B	+3.1%
Sep 2010	$2.10B	-0.4%
Jun 2010	$2.11B	-8.7%
Mar 2010	$2.31B	+6.5%
Dec 2009	$2.17B	+64.1%
Sep 2009	$1.32B	+23.7%
Jun 2009	$1.07B	+27.3%
Mar 2009	$838.00M	+34.7%
Dec 2008	$622.00M	-53.4%
Sep 2008	$1.33B	-16.0%
Jun 2008	$1.59B	+7.1%
Mar 2008	$1.48B	-18.7%
Dec 2007	$1.83B	+1.8%
Sep 2007	$1.79B	+3.3%
Jun 2007	$1.74B	-4.9%
Mar 2007	$1.82B	-5.9%
Dec 2006	$1.94B	+2.3%
Sep 2006	$1.90B	+2.9%
Jun 2006	$1.84B	-1.4%
Mar 2006	$1.87B	-7.2%
Dec 2005	$2.01B	-18.4%
Sep 2005	$2.47B	-5.1%
Jun 2005	$2.60B	-11.0%
Mar 2005	$2.93B	+13.7%
Dec 2004	$2.57B	+15.1%
Sep 2004	$2.24B	+11.1%
Jun 2004	$2.01B	+70.7%
Mar 2004	$1.18B	+2.5%
Dec 2003	$1.15B	+44.7%
Sep 2003	$794.00M	+201.1%
Jun 2003	-$785.00M	-99.2%
Mar 2003	-$394.00M	-13.2%
Dec 2002	-$348.00M	-163.6%
Sep 2002	-$132.00M	-108.4%
Jun 2002	$1.57B	-4.4%
Mar 2002	$1.64B	-5.1%
Dec 2001	$1.73B	-6.4%
Sep 2001	$1.85B	-0.3%
Jun 2001	$1.86B	+7.9%
Mar 2001	$1.72B	+0.2%
Dec 2000	$1.72B	-2.4%
Sep 2000	$1.76B	+36.4%
Jun 2000	$1.29B	-13.8%
Mar 2000	$1.50B	-0.6%
Dec 1999	$1.51B	+5.2%
Sep 1999	$1.43B	-23.7%
Jun 1999	$1.88B	+0.6%
Mar 1999	$1.87B	-16.2%
Dec 1998	$2.23B	+12.4%
Sep 1998	$1.98B	+29.9%
Jun 1998	$1.53B	+57.2%
Mar 1998	$971.00M	+442.5%
Dec 1997	$179.00M	>+9,900.0%
Jun 1997	$0.00	-100.0%
Mar 1997	$54.00M	-

FAQ

What is the current TTM EBITDA of CI?
As of today, CI TTM EBITDA is $10.67B
What is CI TTM EBITDA most recent change?
CI TTM EBITDA was up +12.08% on September 30, 2025
What is 1-year change in CI TTM EBITDA?
CI TTM EBITDA is up +68.27% year-over-year
How far is CI TTM EBITDA from its all-time high?
CI TTM EBITDA is currently -22.71% below its historical high of $13.81B set on March 31, 2021
How does CI TTM EBITDA rank versus sector peers?
CI TTM EBITDA is higher than 98.37% of companies in Healthcare sector
When is CI next earnings release?
The next earnings release for CI is on February 5, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

CI Official Website www.cigna.com
Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1739940/000173994025000037/0001739940-25-000037-index.htm
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1739940/000173994025000009/0001739940-25-000009-index.htm
CI Profile on Yahoo Finance finance.yahoo.com/quote/CI
CI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ci